State Street SPDR SandP Pharmaceuticals ETF (XPH) |
| 55.79 0.18 (0.32%) 01-13 16:00 |
| Open: | 55.58 |
| High: | 55.79 |
| Low: | 54.73 |
| Volume: | 80,460 |
| Market Cap: | 230(M) |
| PE Ratio: | 18.49 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 57.58 |
| Resistance 1: | 56.27 |
| Pivot price: | 56.24 |
| Support 1: | 54.14 |
| Support 2: | 45.04 |
| 52w High: | 57.58 |
| 52w Low: | 35.22 |
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 19 Dec 2025
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Wed, 10 Dec 2025
3 Undervalued ETFs to Buy Before 2026 - Zacks Investment Research
Fri, 28 Nov 2025
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Nasdaq
Thu, 27 Nov 2025
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Tue, 14 Oct 2025
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Mon, 29 Sep 2025
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
